ADVFN US – Market Content Editor

Spotify (NYSE:SPOT) announced Tuesday that premium subscribers in the U.S. and Canada will soon gain access to music videos, marking a major step in the company’s effort to compete more directly with YouTube in the video–music space. The expansion builds on Spotify’s initial beta launch last year across nearly 100 markets. By adding video content—viewed…

Tronox Holdings (NYSE:TROX) rallied 28% after announcing it has received conditional backing for as much as $600 million in potential financing from the Export-Import Bank of the United States (EXIM) and Export Finance Australia (EFA). The funds would help advance the company’s expansion into the rare earth supply chain. The coordinated, non-binding letters of support…

SES AI Corporation (NYSE:SES) saw its shares decline 5% on Tuesday after short-seller Wolfpack Research published a sharply critical report raising questions about the company’s strategy, partnerships, and recent acquisitions. In its report, “SES’s Dying Biz Pivoting into Another AI Pipedream,” Wolfpack alleges that SES AI has been promoting “phantom deals” and touting an AI…

Q/C Technologies, Inc. (NASDAQ:QCLS) saw its stock surge 20% on Tuesday morning after the quantum-class computing firm revealed that Martin Shkreli has joined the company as a Strategic Advisor — marking a high-profile return to the business arena for the polarizing former pharmaceutical executive. The company, which develops computing architectures that rely on light instead…

C3 AI (NYSE:AI) traded 2% higher on Tuesday after announcing it has been awarded a contract by the U.S. Army to build an artificial intelligence–powered logistics system intended to support combat operations. The selection, made by the Army’s Rapid Capabilities and Critical Technologies Office (RCCTO), tasks C3 AI with creating AI-enabled tools that can help…

Akari Therapeutics PLC (NASDAQ:AKTX) saw its stock rise 7.9% in premarket trading on Tuesday after unveiling new preclinical findings showing that its investigational antibody-drug conjugate, AKTX-101, successfully eliminated cancer cells carrying K-Ras G12V mutations in pancreatic cancer models. According to the company, AKTX-101—designed to target the Trop2 protein frequently overexpressed in pancreatic tumors—demonstrated “single digit…

STAAR Surgical Company (NASDAQ:STAA) surged 15% in Tuesday’s premarket session after Alcon (NYSE:ALC) announced it has raised its acquisition offer through an amended merger agreement. Under the revised terms, Alcon will acquire all outstanding STAAR shares for $30.75 per share in cash, adding roughly $150 million in equity value for shareholders. The new offer values…

Citius Oncology Inc. (NASDAQ:CTOR) dropped 13.8% in premarket trading Tuesday after the company unveiled plans to raise roughly $18 million through a combination of registered direct and private placement offerings. The cancer-focused biotech said it reached an agreement with a single institutional healthcare investor to sell shares and warrants at a price of $1.09 per…

SLM Corp. (NASDAQ:SLM) saw its stock plunge 14% in premarket trading Tuesday after the company’s 2025 investor day unveiled a much weaker earnings trajectory and higher-than-expected operating costs. The event, held after Monday’s market close, triggered a wave of analyst downgrades. Morgan Stanley cut its rating from Overweight to Equalweight and reduced its price target…